uniQure
QURE
#5377
Rank
HK$12.49 B
Marketcap
HK$178.14
Share price
-0.35%
Change (1 day)
-12.36%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2026 (TTM): -HK$1.84 Billion

According to uniQure's latest financial reports the company's current earnings are HK$20.16 Million. In 2025 the company made an earning of -HK$1.52 Billion, an increase over its 2024 earnings that were of -HK$1.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$1.84 Billion20.74%
2025 -HK$1.52 Billion-18.47%
2024 -HK$1.87 Billion-22.65%
2023 -HK$2.41 Billion139.01%
2022 -HK$1.01 Billion-138.54%
2021 HK$2.61 B-335.29%
2020 -HK$1.11 Billion13.88%
2019 -HK$0.98 Billion49.51%
2018 -HK$0.66 Billion4.55%
2017 -HK$0.63 Billion12.65%
2016 -HK$0.56 Billion-9.59%
2015 -HK$0.62 Billion66.95%
2014 -HK$0.37 Billion30.8%
2013 -HK$0.29 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
HK$86.69 B-4,826.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$61.09 B-3,430.95%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-HK$0.87 Billion-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-HK$1.57 Billion-14.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$0.34 B-118.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-HK$5.38 Billion 192.82%๐Ÿ‡บ๐Ÿ‡ธ USA